文献速递脑血管病

靶向不同单核/巨噬细胞亚群对实验性卒中结局无影响

Targeting Different Monocyte/Macrophage Subsets Has No Impact on Outcome in Experimental Stroke.
PubMed 文献 · Stroke · 2017-03-14

该研究在小鼠缺血性卒中模型中评估了选择性或非选择性耗竭单核/巨噬细胞以及过继转移促炎(M1)或抗炎(M2)巨噬细胞对结局的影响。结果显示,这些干预均未影响急性期组织损伤和神经行为结局,也未影响长期神经恢复。研究未能将单核/巨噬细胞确定为急性缺血性卒中的相关治疗靶点。

要点

  • 选择性或非选择性耗竭单核/巨噬细胞未改善小鼠卒中急性期结局。
  • M1或M2巨噬细胞转移对急性期组织损伤和神经功能无影响。
  • 靶向单核/巨噬细胞亚群未能成为实验性卒中的有效治疗策略。

核心结论

  • 靶向不同单核/巨噬细胞亚群对小鼠缺血性卒中结局无影响。
  • 研究未能将单核/巨噬细胞确定为急性缺血性卒中的相关治疗靶点。

研究设计与样本

  • 小鼠短暂性大脑中动脉闭塞模型,分别给予氯膦酸盐脂质体非选择性耗竭巨噬细胞、MC-21抗体选择性耗竭促炎Ly-6Chigh单核细胞、或过继转移M1/M2巨噬细胞。
  • 另在光血栓性卒中模型中评估MC-21抗体和M2巨噬细胞转移对长期神经恢复的影响。

主要发现

  • 选择性和非选择性单核/巨噬细胞耗竭以及M1和M2巨噬细胞转移均未影响大脑中动脉闭塞急性期的组织损伤和神经行为结局。
  • 选择性耗竭Ly-6Chigh单核细胞和M2巨噬细胞转移对光血栓性卒中后的神经恢复无影响。

临床怎么用

  • 基于本实验模型结果,不应将单核/巨噬细胞亚群作为急性缺血性卒中的治疗靶点进行临床转化。

局限性

  • 研究仅在小鼠模型中进行,结论外推至人类需谨慎。
  • 未报告样本量、效应值及统计显著性等具体数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Peripheral immune cell infiltration contributes to neural injury after ischemic stroke. However, in contrast to lymphocytes and neutrophils, the role of different monocyte/macrophage subsets remains to be clarified. Therefore, we evaluated the effects of selective and unselective monocyte/macrophage depletion and proinflammatory (M1-) and anti-inflammatory (M2-) macrophage transfer on the outcome after experimental cerebral ischemia. METHODS: To assess short-term effects of monocytes/macrophages in acute ischemic stroke, mice underwent transient middle cerebral artery occlusion and received either clodronate liposomes for unselective macrophage depletion, MC-21-antibody for selective depletion of proinflammatory Ly-6Chigh monocytes, or proinflammatory (M1-) or anti-inflammatory (M2-) macrophage transfer. In addition, the impact of MC-21-antibody administration and M2-macrophage transfer on long-term neural recovery was investigated after photothrombotic stroke. Neurobehavioral tests were used to analyze functional outcomes, infarct volumes were determined, and immunohistochemical analyses were performed to characterize the postischemic inflammatory reaction. RESULTS: Selective and unselective monocyte/macrophage depletion and M1- and M2-macrophage transfer did not influence tissue damage and neurobehavioral outcomes in the acute phase after middle cerebral artery occlusion. Beyond, selective depletion of Ly-6Chigh monocytes and M2-macrophage transfer did not have an impact on neural recovery after photothrombotic stroke. CONCLUSIONS: Targeting different monocyte/macrophage subsets has no impact on outcome after ischemic stroke in mice. Altogether, our study could not identify monocytes/macrophages as relevant therapeutic targets in acute ischemic stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Schmidt A, Strecker JK, Hucke S, et al. Targeting Different Monocyte/Macrophage Subsets Has No Impact on Outcome in Experimental Stroke. Stroke. 2017. PMID: 28292872. doi:10.1161/STROKEAHA.116.015577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。